tailieunhanh - Real-life experience with benralizumab during 6 months

Benralizumab is a monoclonal antibody that binds to the human interleukin-5 (IL-5) receptor (IL-5R), thereby preventing IL-5 from binding to its receptor and inhibiting differentiation and maturation of eosinophils in the bone marrow. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN